Clinical Trial Update: Efficacy & Safety of Anticoagulants in Cirrhosis ± HCC [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating the efficacy and safety of anticoagulants in patients with cirrhosis, with or without hepatocellular carcinoma. The study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis
• Hepatocellular Carcinoma
• Portal Vein Thrombosis

Snippet

Sponsor: Mansoura University | Conditions: Cirrhosis, HCC - Hepatocellular Carcinoma | Phase 4 | Status: RECRUITING